| Dr Tuongvy Zamurs, DO | |
|
1707 Cole Blvd Ste 100, Golden, CO 80401-3219 | |
| (303) 763-4900 | |
| Not Available |
| Full Name | Dr Tuongvy Zamurs |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 1707 Cole Blvd Ste 100, Golden, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124467808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | DR.0055037 (Colorado) | Primary |
| Entity Name | New West Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427010859 PECOS PAC ID: 9537054614 Enrollment ID: O20040218000087 |
News Archive
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.
The powerful chemotherapy and radiation used to save cancer patients' lives can also destroy their fertility.
To evaluate and understand the adherence to public health actions recommended by the government, a team in Norway undertook a study funded in part by the Norwegian Research Council's Centres of Excellence Funding Scheme and by the project: A realtime analytical pipeline for preparedness, planning, and response during the COVID-19 pandemic in Norway.
With pancreatic cancer poised to become the third leading cause of cancer death in Europe, Celgene International Sàrl, a subsidiary of Celgene Corporation, has today reiterated its commitment to patients and their families with the announcement that it will focus significant resources to increase awareness and understanding of the disease.
The data Medicare uses to publicly report hospital rates of patients developing pressure ulcers (or bedsores) is not an accurate source for comparing hospitals on how well they prevent the condition, says a new University of Michigan study.
› Verified 1 days ago
| Entity Name | Colorado Hospitalist Services, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265806178 PECOS PAC ID: 4486957578 Enrollment ID: O20160123000040 |
News Archive
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.
The powerful chemotherapy and radiation used to save cancer patients' lives can also destroy their fertility.
To evaluate and understand the adherence to public health actions recommended by the government, a team in Norway undertook a study funded in part by the Norwegian Research Council's Centres of Excellence Funding Scheme and by the project: A realtime analytical pipeline for preparedness, planning, and response during the COVID-19 pandemic in Norway.
With pancreatic cancer poised to become the third leading cause of cancer death in Europe, Celgene International Sàrl, a subsidiary of Celgene Corporation, has today reiterated its commitment to patients and their families with the announcement that it will focus significant resources to increase awareness and understanding of the disease.
The data Medicare uses to publicly report hospital rates of patients developing pressure ulcers (or bedsores) is not an accurate source for comparing hospitals on how well they prevent the condition, says a new University of Michigan study.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tuongvy Zamurs, DO 1707 Cole Blvd Ste 100, Golden, CO 80401-3219 Ph: (303) 763-4900 | Dr Tuongvy Zamurs, DO 1707 Cole Blvd Ste 100, Golden, CO 80401-3219 Ph: (303) 763-4900 |
News Archive
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.
The powerful chemotherapy and radiation used to save cancer patients' lives can also destroy their fertility.
To evaluate and understand the adherence to public health actions recommended by the government, a team in Norway undertook a study funded in part by the Norwegian Research Council's Centres of Excellence Funding Scheme and by the project: A realtime analytical pipeline for preparedness, planning, and response during the COVID-19 pandemic in Norway.
With pancreatic cancer poised to become the third leading cause of cancer death in Europe, Celgene International Sàrl, a subsidiary of Celgene Corporation, has today reiterated its commitment to patients and their families with the announcement that it will focus significant resources to increase awareness and understanding of the disease.
The data Medicare uses to publicly report hospital rates of patients developing pressure ulcers (or bedsores) is not an accurate source for comparing hospitals on how well they prevent the condition, says a new University of Michigan study.
› Verified 1 days ago
Dr. Donald Jerome Murphy, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5920 Mcintyre St, Golden, CO 80403 Phone: 720-434-4876 Fax: 303-225-4246 | |
Dr. John Martin Hiner, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 5920 Mcintyre Street, Golden, CO 80403 Phone: 303-949-1250 | |
Dr. Bookanakere Niranjan, M.D., M.P.H. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5920 Mcintyre St, Golden, CO 80403 Phone: 303-949-1250 | |
Dr. Leslie Beth Eber, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5920 Mcintyre St, Golden, CO 80403 Phone: 303-949-1250 | |
Dr. Mary Kosco Tuuk, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5920 Mcintyre St, Golden, CO 80403 Phone: 303-949-1250 | |
Dr. Steven Mark, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 177 Alpine Ave, Golden, CO 80401 Phone: 303-670-0364 |